Caption Management, LLC Spring Works Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $6.4 Million - $12.6 Million	337,900 New	337,900 $12.3 Million
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $6.24 Million - $8.51 Million	-250,000 Reduced 65.79%	130,000 $3.35 Million
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $4.25 Million - $5.61 Million	195,500 Added 105.96%	380,000 $9.88 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $4.45 Million - $7.32 Million	184,500 New	184,500 $5.26 Million
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $3.8 Million - $5.07 Million	77,500 New	77,500 $4.37 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.34B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.